Company intelligence / Profile preview

Human BioSciences

Gaithersburg, Maryland, United Stateshumanbiosciences.com ↗

Ownership: Private
Employees: ~46
Development stage: Commercial

Overview

Human BioSciences pioneered the use of preserved native bovine collagen in wound care. Their FDA-cleared Kollagen™ products were among the first advanced wound dressings to allow direct interaction with wounds for improved healing. The company’s products are widely used in clinical practice and have contributed to establishing collagen as a standard of care in advanced wound management[2][4].

Therapeutic areas: Dermatology
Modalities: Collagen-based biomaterials
Industry: Consumable Medical Devices

Drug pipeline

3 assets

Medifil II

Commercial

Indications: Wounds, Burns, Ulcers

2 more assets in the full pipeline.

Request access →

Partnerships

Not explicitly listed; company notes global expansion through partnerships and contract research/manufacturing services

Beyond the preview

Go deeper on Human BioSciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human BioSciences.

Explore the full profile